Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA)

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(10 sites)

France

CHU Amiens - Hopital Nord, Amiens

Bicêtre University Hospital, Le Kremlin-Bicêtre

Germany

Children's university hospital Charité, Campus Virchow, SPZ, Berlin

Hamburger Zentrum fur Kinder und Jugendrheumatologie, Hamburg

Asklepios Klinik Sankt Augustin GmbH, Sankt Augustin

Poland

Malopolskie Badania Kliniczne, Krakow

Spain

Hospital Universitari Vall d'Hebron, Barcelona

Hospital Sant Joan de Deu, Barcelona

Hospital Universitari i Politecnic La Fe, Valencia

United Kingdom

Great Ormond Street Hospital, London